首页> 外文期刊>Transplant immunology >Failure of chimerism formation and tolerance induction from Fas ligand mutant bone marrow donors after nonmyeloablative conditioning
【24h】

Failure of chimerism formation and tolerance induction from Fas ligand mutant bone marrow donors after nonmyeloablative conditioning

机译:非清髓性调节后Fas配体突变体骨髓供体的嵌合体形成和耐受诱导失败

获取原文
获取原文并翻译 | 示例
           

摘要

Formation of donor-recipient mixed chimerism after nonmyeloablative conditioning allows co-existence of donor and recipient hematopoietic stem cells, with solid organ allograft tolerance and less likeliness of graft versus host development. Using a post-transplant bronchiolitis obliterans murine model, we aimed to test the hypothesis that allograft preservation after mixed chimerism formation is dependent on the presence of a functional Fas ligand (FasL) on donor hematopoietic cells. To form mixed chimerism, two aliquots of 30×106 whole bone marrow cells (BMC) from either wild-type C57BL/6 in one group, or transgenic gld mice with mutant FasL (d=0 and 2+) in the other were used, with both groups receiving intravenous busulfan (10mg/kg) on d-1 and intraperitoneal cyclophosphamide (200mg/kg) on d+1. Tracheal allografts obtained from C57BL/6 mice were implanted into recipient BALB/c mice subcutaneously on d=0. Tracheal allografts were harvested at d+28 post-transplant and were evaluated by histopathology. Mixed chimerism formation was detected in wild type C57BL/6 whole BMC recipients, which was accompanied by tracheal allograft acceptance with near normal structure at d+28 post implantation. However, in recipients of FasL mutant whole BMC, neither mixed chimerism formation nor tracheal allograft acceptance was obtained. We thus conclude that bone marrow cells lacking functional FasL molecules could not be engrafted in allogeneic recipients to form stable mixed chimerism after nonmyeloablative conditioning, thus not allowing tracheal allograft acceptance.
机译:非清髓性调节后供体-受体混合嵌合体的形成允许供体和受体造血干细胞共存,并具有同种异体器官耐受性,并且移植物与宿主发育的可能性较小。使用移植后闭塞性细支气管炎小鼠模型,我们旨在检验以下假设:混合嵌合体形成后同种异体移植物的保存取决于供体造血细胞上功能性Fas配体(FasL)的存在。为了形成混合嵌合体,使用了两个等分试样,分别来自一组野生型C57BL / 6的30×106个完整骨髓细胞(BMC),或另一组带有突变FasL(d = 0和2+)的转基因gld小鼠,两组均在d-1时接受静脉注射白消安(10mg / kg),在d + 1时接受腹膜内环磷酰胺(200mg / kg)。将从C57BL / 6小鼠获得的气管同种异体移植物在d = 0下皮下植入受体BALB / c小鼠中。移植后第28天收获气管同种异体移植物,并通过组织病理学评估。在野生型C57BL / 6全BMC受体中检测到混合嵌合体形成,并在植入后d + 28时伴有气管同种异体移植,结构接近正常。但是,在FasL突变体整个BMC的受体中,既没有混合嵌合体形成,也没有获得气管同种异体移植接受。因此,我们得出的结论是,缺乏功能性FasL分子的骨髓细胞不能移植到同种异体受体中,经过非清髓性调节后,就可以形成稳定的混合嵌合体,因此不能接受气管同种异体移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号